Clinical Trial: Drug-Drug Interaction Between R1_PBK_M2301 and R2_PBK_M2301 in Healthy Adults

U.S., June 13 -- ClinicalTrials.gov registry received information related to the study (NCT07017335) titled 'Drug-Drug Interaction Between R1_PBK_M2301 and R2_PBK_M2301 in Healthy Adults' on May 23.

Brief Summary: This is a Phase 1, open-label, randomized, crossover clinical trial designed to evaluate the potential drug-drug interaction (DDI) between R1_PBK_M2301 (levodropropizine 60 mg) and R2_PBK_M2301 (Pelargonium sidoides ethanol extract 11%) in healthy adult volunteers. The study aims to assess the pharmacokinetics of each investigational drug when administered alone and in combination. Approximately [insert number] healthy subjects will participate in two treatment periods with appropriate washout intervals. Safety, tolerability, and...